A reasonable chance it could cause serious harm or death.
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
| Distributed by / for | Glaxosmithkline Consumer Healthcare Holdings DBA Haleon |
| Full product label | Advil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-count bottles (UPC 3 0573 0154 21 5), Pfizer, Madison, NJ 07940 |
| Recalling firm | Glaxosmithkline Consumer Healthcare Holdings DBA Haleon |
| Distribution | Nationwide in the USA. |
| Quantity | 321,246 tablets |
| Recall initiated | 2022-12-06 |
| Report date | 2023-02-01 |
| Recall completed | 2024-02-26 |
| Recall number | D-0181-2023 |
| Classification | Class I |
| FDA status | Terminated |
| Origin on file | Warren NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗